| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.76e-04 | 363 | 46 | 6 | GO:0106310 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 1.92e-04 | 709 | 46 | 8 | GO:0016773 | |
| GeneOntologyMolecularFunction | kinase activity | 3.18e-04 | 764 | 46 | 8 | GO:0016301 | |
| GeneOntologyMolecularFunction | protein kinase activity | 4.13e-04 | 600 | 46 | 7 | GO:0004672 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 5.28e-04 | 446 | 46 | 6 | GO:0004674 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 1.23e-03 | 938 | 46 | 8 | GO:0016772 | |
| Domain | - | 2.62e-04 | 679 | 47 | 8 | 3.30.160.60 | |
| Domain | KRAB | 2.63e-04 | 358 | 47 | 6 | PS50805 | |
| Domain | zf-C2H2 | 3.01e-04 | 693 | 47 | 8 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 3.04e-04 | 694 | 47 | 8 | IPR013087 | |
| Domain | KRAB | 3.09e-04 | 369 | 47 | 6 | SM00349 | |
| Domain | KRAB | 3.14e-04 | 370 | 47 | 6 | IPR001909 | |
| Domain | ZINC_FINGER_C2H2_2 | 6.34e-04 | 775 | 47 | 8 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 6.45e-04 | 777 | 47 | 8 | PS00028 | |
| Domain | Znf_C2H2-like | 7.55e-04 | 796 | 47 | 8 | IPR015880 | |
| Domain | Znf_C2H2 | 8.13e-04 | 805 | 47 | 8 | IPR007087 | |
| Domain | ZnF_C2H2 | 8.33e-04 | 808 | 47 | 8 | SM00355 | |
| Domain | zf-C2H2_6 | 1.12e-03 | 314 | 47 | 5 | PF13912 | |
| Domain | KRAB | 1.99e-03 | 358 | 47 | 5 | PF01352 | |
| Domain | Kinase-like_dom | 2.27e-03 | 542 | 47 | 6 | IPR011009 | |
| Domain | Pkinase | 2.61e-03 | 381 | 47 | 5 | PF00069 | |
| Domain | PROTEIN_KINASE_ATP | 5.76e-03 | 459 | 47 | 5 | PS00107 | |
| Domain | CUB | 6.76e-03 | 49 | 47 | 2 | PF00431 | |
| Domain | DnaJ | 6.76e-03 | 49 | 47 | 2 | SM00271 | |
| Domain | DNAJ_1 | 6.76e-03 | 49 | 47 | 2 | PS00636 | |
| Domain | DNAJ_2 | 6.76e-03 | 49 | 47 | 2 | PS50076 | |
| Domain | - | 6.76e-03 | 49 | 47 | 2 | 1.10.287.110 | |
| Domain | CUB | 7.03e-03 | 50 | 47 | 2 | SM00042 | |
| Domain | DnaJ_domain | 7.31e-03 | 51 | 47 | 2 | IPR001623 | |
| Domain | Prot_kinase_dom | 7.48e-03 | 489 | 47 | 5 | IPR000719 | |
| Domain | - | 7.59e-03 | 52 | 47 | 2 | 2.60.120.290 | |
| Domain | PROTEIN_KINASE_DOM | 7.74e-03 | 493 | 47 | 5 | PS50011 | |
| Domain | CUB | 7.87e-03 | 53 | 47 | 2 | PS01180 | |
| Domain | CUB_dom | 9.06e-03 | 57 | 47 | 2 | IPR000859 | |
| Pubmed | 7.62e-07 | 230 | 48 | 6 | 35449600 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.36e-06 | 861 | 48 | 9 | 36931259 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 37694282 | ||
| Pubmed | 2.93e-05 | 1487 | 48 | 10 | 33957083 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 27875067 | ||
| Pubmed | Association of polo-like kinase with alpha-, beta- and gamma-tubulins in a stable complex. | 3.90e-05 | 7 | 48 | 2 | 10191277 | |
| Pubmed | Analysis of BCL6-interacting proteins by tandem mass spectrometry. | 8.81e-05 | 62 | 48 | 3 | 16147992 | |
| Pubmed | 1.05e-04 | 549 | 48 | 6 | 38280479 | ||
| Pubmed | 1.11e-04 | 67 | 48 | 3 | 30669930 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 1.22e-04 | 564 | 48 | 6 | 21565611 | |
| Pubmed | 1.27e-04 | 568 | 48 | 6 | 37774976 | ||
| Pubmed | 1.42e-04 | 191 | 48 | 4 | 31177093 | ||
| Pubmed | 1.62e-04 | 76 | 48 | 3 | 27542412 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 1.75e-04 | 1489 | 48 | 9 | 28611215 | |
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 1.88e-04 | 80 | 48 | 3 | 19389623 | |
| Pubmed | Functional analysis of candidate genes from genome-wide association studies of hearing. | 2.50e-04 | 17 | 48 | 2 | 31927188 | |
| Pubmed | 2.50e-04 | 17 | 48 | 2 | 17634284 | ||
| Pubmed | 2.52e-04 | 222 | 48 | 4 | 37071664 | ||
| Pubmed | 2.58e-04 | 89 | 48 | 3 | 36861887 | ||
| Pubmed | 2.62e-04 | 650 | 48 | 6 | 38777146 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | 2.74e-04 | 1242 | 48 | 8 | 30973865 | |
| Pubmed | 2.89e-04 | 230 | 48 | 4 | 29513927 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 3.13e-04 | 235 | 48 | 4 | 28378594 | |
| Pubmed | TRIM21-mediated proteasomal degradation of SAMHD1 regulates its antiviral activity. | 3.14e-04 | 19 | 48 | 2 | 31797533 | |
| Pubmed | 3.49e-04 | 20 | 48 | 2 | 2542606 | ||
| Pubmed | 3.49e-04 | 20 | 48 | 2 | 7479878 | ||
| Pubmed | 3.85e-04 | 21 | 48 | 2 | 6457647 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 4.14e-04 | 1321 | 48 | 8 | 27173435 | |
| Pubmed | 4.34e-04 | 1006 | 48 | 7 | 15226823 | ||
| Pubmed | 4.86e-04 | 730 | 48 | 6 | 34857952 | ||
| Pubmed | 4.96e-04 | 733 | 48 | 6 | 34672954 | ||
| Pubmed | 5.05e-04 | 24 | 48 | 2 | 32212159 | ||
| Pubmed | 5.33e-04 | 114 | 48 | 3 | 21150319 | ||
| Pubmed | Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. | 5.48e-04 | 25 | 48 | 2 | 23563309 | |
| Pubmed | 5.93e-04 | 26 | 48 | 2 | 24067654 | ||
| Pubmed | 6.42e-04 | 504 | 48 | 5 | 34432599 | ||
| Pubmed | Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. | 6.89e-04 | 28 | 48 | 2 | 24462114 | |
| Pubmed | 7.92e-04 | 30 | 48 | 2 | 19054571 | ||
| Pubmed | 8.16e-04 | 132 | 48 | 3 | 26439863 | ||
| Pubmed | 8.45e-04 | 31 | 48 | 2 | 14630798 | ||
| Pubmed | Genome-wide association study of lung function decline in adults with and without asthma. | 9.01e-04 | 32 | 48 | 2 | 22424883 | |
| Pubmed | 1.14e-03 | 332 | 48 | 4 | 37433992 | ||
| Pubmed | Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. | 1.34e-03 | 39 | 48 | 2 | 19010793 | |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 1.34e-03 | 157 | 48 | 3 | 30686591 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 8.26e-05 | 718 | 37 | 8 | 28 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 4.51e-03 | 49 | 37 | 2 | 584 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.97e-03 | 181 | 37 | 3 | 694 | |
| GeneFamily | EF-hand domain containing | 1.01e-02 | 219 | 37 | 3 | 863 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 2.16e-05 | 856 | 48 | 9 | M4500 | |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 4.45e-05 | 107 | 48 | 4 | MM947 | |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 4.78e-05 | 109 | 48 | 4 | M2451 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.61e-06 | 184 | 48 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.79e-06 | 188 | 48 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_basal-Dividing_Basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.25e-06 | 197 | 48 | 5 | 0a6754a5109bec0d0de42adbfdf4db43ff60c3d2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.85e-05 | 163 | 48 | 4 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-05 | 164 | 48 | 4 | 0662cd9d21608efacc336e0a582859f3b9a4951d | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-05 | 168 | 48 | 4 | ca65321259711321c175ede67bd67a47aad81d7a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.44e-05 | 171 | 48 | 4 | c3e3ea09c73050372314a89b282e36ba5f339d73 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.44e-05 | 171 | 48 | 4 | 0eea035fde32cc2a75a0d4227911edb5d54ed47e | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.68e-05 | 174 | 48 | 4 | 46cbb462173a684ceb9e680f9259dc3b133763f7 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-05 | 175 | 48 | 4 | 9142ed8ca2f1c0c518deb21988221406f62fe38c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-05 | 175 | 48 | 4 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-05 | 175 | 48 | 4 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | NS-moderate-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.94e-05 | 177 | 48 | 4 | 174c54acfe19e2bb31418d69e228032ba724cbb6 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-05 | 179 | 48 | 4 | dfd9d29281510d32f1a2e8336d2e58ef496cfd1d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-05 | 180 | 48 | 4 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.20e-05 | 180 | 48 | 4 | 38035cf2c6fbc443ea10ca7e942572715ed572da | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.29e-05 | 181 | 48 | 4 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.39e-05 | 182 | 48 | 4 | 1c1a687f728341c209b048b6715bcddd0ac20069 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.39e-05 | 182 | 48 | 4 | 97bb07478f56a937b490fba121ee603db64134a1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.58e-05 | 184 | 48 | 4 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 4.58e-05 | 184 | 48 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.58e-05 | 184 | 48 | 4 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.67e-05 | 185 | 48 | 4 | 282b3de8850f3c21704339e8d8737b432a43441a | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.67e-05 | 185 | 48 | 4 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.67e-05 | 185 | 48 | 4 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-05 | 189 | 48 | 4 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.08e-05 | 189 | 48 | 4 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.18e-05 | 190 | 48 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 5.18e-05 | 190 | 48 | 4 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.18e-05 | 190 | 48 | 4 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.18e-05 | 190 | 48 | 4 | b69940d16685249167d4c2cf6ad8237ccf6f7590 | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 5.29e-05 | 191 | 48 | 4 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | (3)_Macrophage_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.29e-05 | 191 | 48 | 4 | b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.40e-05 | 192 | 48 | 4 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.40e-05 | 192 | 48 | 4 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-05 | 192 | 48 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 5.51e-05 | 193 | 48 | 4 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.62e-05 | 194 | 48 | 4 | d840c1949c328779426c9172e02da09e968f0567 | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.62e-05 | 194 | 48 | 4 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.62e-05 | 194 | 48 | 4 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.62e-05 | 194 | 48 | 4 | d790cfff3664e46fe2fd2f6b0c26896799927845 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.73e-05 | 195 | 48 | 4 | 6e875c83f838241b5fcaf4a3249b1408d74521dc | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.73e-05 | 195 | 48 | 4 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 195 | 48 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 195 | 48 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-05 | 196 | 48 | 4 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.97e-05 | 197 | 48 | 4 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.97e-05 | 197 | 48 | 4 | e132f4b9deef6a565262c0aa0863cafe28f248e6 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.97e-05 | 197 | 48 | 4 | d1cb30ec4f3024541e9876c70bf63fe4d5c55bf1 | |
| ToppCell | (4)_B_cells-(4)_B_Hypermutation|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.08e-05 | 198 | 48 | 4 | 8be724a49b4c911d68c3e82fb75e96722d0eaa03 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.08e-05 | 198 | 48 | 4 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.08e-05 | 198 | 48 | 4 | 55ea8c9d2154ded74c7b851735b24c95bae01de4 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.08e-05 | 198 | 48 | 4 | 7225a6194c52b01c581e58d3cda107c4af96dc4f | |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.08e-05 | 198 | 48 | 4 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | 6.08e-05 | 198 | 48 | 4 | e86c1224f5b0890a50a25257628e90c790aae7cd | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.08e-05 | 198 | 48 | 4 | fc7d8b8e710eedd6cfc1e5393f0c23feac283807 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.08e-05 | 198 | 48 | 4 | ddec07c7bc26d35f155537d907b46e2cb5b55b5f | |
| ToppCell | (1)_T_cell_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.08e-05 | 198 | 48 | 4 | dac3a16e3a070a37f4d0ea37633c23fdc8a9c70a | |
| ToppCell | (0)_NK_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.08e-05 | 198 | 48 | 4 | c5336d9b802393d6fd6f8446ea4bb6befeb97bfd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.08e-05 | 198 | 48 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating-AT2_proliferating_L.0.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-05 | 199 | 48 | 4 | d7dbc551c05da32c698908348572fb0ce1166e10 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.20e-05 | 199 | 48 | 4 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | proximal-3-Epithelial-Proliferating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.20e-05 | 199 | 48 | 4 | 2263bb73d9c5693b44d91d2548305efc1b6e4079 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_ventral_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 6.20e-05 | 199 | 48 | 4 | 446cd7d960812519fe2b8e434578ef0b668c75ce | |
| ToppCell | proximal-Epithelial-Proliferating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.20e-05 | 199 | 48 | 4 | 521ff4ae3437c8ba477a0a42b9da195af976c3ff | |
| ToppCell | (2)_B_cell-(24)_B_cell_cycling|(2)_B_cell / shred on Cell_type and subtype | 6.20e-05 | 199 | 48 | 4 | d5a9a8a71c4de8cbcef947943f60838731bc640b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.20e-05 | 199 | 48 | 4 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-05 | 199 | 48 | 4 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.20e-05 | 199 | 48 | 4 | 7816ad127b16208b1046da53f4a295b4a747b4cc | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.20e-05 | 199 | 48 | 4 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.20e-05 | 199 | 48 | 4 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 6.20e-05 | 199 | 48 | 4 | dee1cf8ee850a2bd57349418a9bcc0948fe9ac9e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-05 | 199 | 48 | 4 | 6a89c3a65fa50af92585c52bec203bcff6f94efc | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.20e-05 | 199 | 48 | 4 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.20e-05 | 199 | 48 | 4 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | (1)_T_cells-(1)_T_cell_dividing|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.20e-05 | 199 | 48 | 4 | 33afdd1b1b951b360ababf440bc556fd9e1c1db2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.20e-05 | 199 | 48 | 4 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | proximal-Epithelial-Proliferating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.20e-05 | 199 | 48 | 4 | e8549b2c4152cb23548351d9cee27c3805892cd8 | |
| ToppCell | Biopsy_IPF-Epithelial-Proliferating_Epithelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 6.33e-05 | 200 | 48 | 4 | 63c5402f050fdb12abab3c8b7f33d4914ae26b9b | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | d70bad979299615fcba707ba21296020918705e6 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.33e-05 | 200 | 48 | 4 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.33e-05 | 200 | 48 | 4 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.33e-05 | 200 | 48 | 4 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.33e-05 | 200 | 48 | 4 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.33e-05 | 200 | 48 | 4 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | (0)_NK_cells-(0)_NK_dividing|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.33e-05 | 200 | 48 | 4 | 1a630bb327070ffcb111ec36bd8fd4be3627ca2a | |
| ToppCell | (3)_MNP-(3)_DC_Monocyte_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.33e-05 | 200 | 48 | 4 | d94fe9bd6ee7c1fed14666f24de41bda014e299b | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.33e-05 | 200 | 48 | 4 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | 38c21ec379005f688df33aea65237a063c476c2e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 6.33e-05 | 200 | 48 | 4 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 6.33e-05 | 200 | 48 | 4 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.33e-05 | 200 | 48 | 4 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | (24)_B_cell_cycling|World / shred on Cell_type and subtype | 6.57e-05 | 202 | 48 | 4 | a7c9b6b173701348ba35fbb975e0bdd3c1f1d5fe | |
| ToppCell | (18)_cycling_gd_T|World / shred on Cell_type and subtype | 6.70e-05 | 203 | 48 | 4 | 7d58929058c4769226a29febee1fd8ba64bc9f1a | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-04 | 116 | 48 | 3 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.30e-04 | 125 | 48 | 3 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-04 | 132 | 48 | 3 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | mild_COVID-19-B_cell|mild_COVID-19 / disease group, cell group and cell class (v2) | 3.88e-04 | 132 | 48 | 3 | 4b372483bc106aecc7b96a09131e1695e54e7dc4 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.00e-04 | 144 | 48 | 3 | 3ba7f8bd6d1c551048403c94693d63e60f7cbbb7 | |
| Computational | Genes in the cancer module 207. | 2.17e-04 | 226 | 27 | 5 | MODULE_207 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 2.81e-04 | 85 | 44 | 3 | DOID:9744 (is_implicated_in) | |
| Disease | Infiltrating duct carcinoma of female breast | 4.48e-04 | 21 | 44 | 2 | C3165106 | |
| Disease | Strabismus | 8.60e-04 | 29 | 44 | 2 | HP_0000486 | |
| Disease | cerebrospinal fluid clusterin measurement | 1.25e-03 | 35 | 44 | 2 | EFO_0007657 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.40e-03 | 37 | 44 | 2 | EFO_0022252 | |
| Disease | triacylglycerol 50:3 measurement | 1.55e-03 | 39 | 44 | 2 | EFO_0010410 | |
| Disease | renal cell carcinoma | 1.80e-03 | 42 | 44 | 2 | EFO_0000681 | |
| Disease | triglycerides in large LDL measurement | 1.89e-03 | 43 | 44 | 2 | EFO_0022319 | |
| Disease | serum non-albumin protein measurement | 2.03e-03 | 361 | 44 | 4 | EFO_0004568 | |
| Disease | phospholipids in medium LDL measurement | 2.44e-03 | 49 | 44 | 2 | EFO_0022183 | |
| Disease | cholesterol in medium LDL measurement | 2.44e-03 | 49 | 44 | 2 | EFO_0022224 | |
| Disease | phospholipids in medium VLDL measurement | 2.75e-03 | 52 | 44 | 2 | EFO_0022154 | |
| Disease | total lipids in medium LDL | 2.75e-03 | 52 | 44 | 2 | EFO_0022180 | |
| Disease | interleukin 12 measurement | 2.85e-03 | 53 | 44 | 2 | EFO_0004753 | |
| Disease | total lipids in medium VLDL | 2.96e-03 | 54 | 44 | 2 | EFO_0022153 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CESGFKDKSDGDFGK | 981 | Q6UB99 | |
| GSSVSFHCDDGFVKT | 716 | Q96PZ7 | |
| GSDEFDKCLSNDKFS | 446 | Q9NZJ5 | |
| VFGEKCEFKGSLSGS | 351 | Q676U5 | |
| TCGKFETNGTDVDSF | 696 | Q9NXL2 | |
| CLSSGKSEGDDSGFT | 151 | Q9C0I3 | |
| SARCSFSDFFEGIGK | 686 | Q5TGY3 | |
| SKSGKDASFESGAGD | 1916 | Q5H9R4 | |
| FCSDGQSFVTASDDK | 111 | Q8NBT0 | |
| FSEGSKTDATDGKDY | 1186 | P46821 | |
| RSECSSDFGGKDSVT | 786 | Q14C86 | |
| FSASECSSQGGFKTK | 991 | Q9HC56 | |
| SKGGKTDFQSSDCLA | 311 | O15018 | |
| FCSAASIGKEESDTG | 101 | O14976 | |
| KFLADGGSADTCDQF | 166 | Q9GZV1 | |
| SDYAEKSTGKGDSCD | 1061 | P46100 | |
| DGSGCSKQSGSFRKF | 681 | O75173 | |
| FEFGTSETFSATCKK | 621 | Q9Y6T7 | |
| FCGEEKSSDFSGEKK | 71 | Q8IY85 | |
| GEKSYDFLTGFTDSC | 66 | A8MTL9 | |
| AFSLFDKDGDGCITT | 16 | P27482 | |
| FGIDCASGDTFTDKA | 421 | Q96RP9 | |
| DEAKGATSDFSGKAF | 431 | Q9NZJ4 | |
| LTECSFKDGAGNSFD | 1366 | P11717 | |
| HTGKGEKCFSERDFS | 661 | Q6P4F7 | |
| CGRFEGSSTTKDDYK | 331 | Q8IYX7 | |
| KGFKAHFFSDKDECS | 721 | O43897 | |
| HFFSDKDECSKDNGG | 726 | O43897 | |
| CEGAKDGFQDSKSSS | 1101 | Q9Y2K2 | |
| LFSKKDSSGGDSCAS | 61 | Q9HA65 | |
| KCDECGKSFSDGSNF | 251 | Q7Z7L9 | |
| DEFFSEGCAPGSKKD | 496 | P02787 | |
| KAGLSGQADFDDFCS | 391 | O15027 | |
| STAETFGFEAKAGKC | 556 | Q6ZQN7 | |
| ECKECGKAFSSSSVF | 281 | Q6ZNG0 | |
| KECGKAFSDGSSFAR | 321 | Q9BX82 | |
| EDCGKAFNGSSIFTK | 201 | Q96N22 | |
| FVCGKGFSKSSLSSD | 651 | A6NK53 | |
| GCSTALGGSSFFEKD | 256 | O43294 | |
| EYEDSGGSKTFSAKD | 681 | Q9NV66 | |
| LDDFTCEKIGSGFFS | 56 | Q96S53 | |
| CSKATEGDNTEFGAF | 1426 | Q96QT4 | |
| TVRFSGADKSFCSEG | 741 | Q5VZL5 | |
| DFDSFACTTVTDSKG | 396 | Q9HCK0 | |
| DDSFTTFFCETGAGK | 46 | P68366 | |
| ECGKSFAESSSFTKH | 776 | B7Z6K7 | |
| FSASGAAEDCNKSKS | 51 | Q5SQQ9 | |
| KGGFAKCFEISDADT | 61 | P53350 | |
| TGEKAFDCSDSGKSF | 151 | Q14584 | |
| ECKECGKAFSSSSSF | 521 | Q14584 |